Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma
Description
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." MeSH
Hierarchy View
Subtype Terms (20)
Adenocarcinoma
205 drugs (113 approved, 92 experimental)
Carcinoma, Adenosquamous
13 drugs (8 approved, 5 experimental)
Carcinoma, Basal Cell
93 drugs (52 approved, 41 experimental)
Carcinoma, Giant Cell
18 drugs (15 approved, 3 experimental)
Carcinoma in Situ
19 drugs (14 approved, 5 experimental)
Carcinoma, Large Cell
11 drugs (9 approved, 2 experimental)
Carcinoma, Ovarian Epithelial
150 drugs (61 approved, 89 experimental)
Carcinoma, Small Cell
35 drugs (18 approved, 17 experimental)
Carcinoma, Squamous Cell
336 drugs (137 approved, 199 experimental)
Carcinoma, Transitional Cell
368 drugs (124 approved, 244 experimental)
Carcinoma, Verrucous
60 drugs (38 approved, 22 experimental)
Mammary Analogue Secretory Carcinoma
Nasopharyngeal Carcinoma
172 drugs (73 approved, 99 experimental)
Non-Muscle Invasive Bladder Neoplasms
1 experimental drug
Thyroid Carcinoma, Anaplastic
29 drugs (17 approved, 12 experimental)
Approved Indicated Drugs (15)
Phase 3 Indicated Drugs (51)
Phase 2 Indicated Drugs (105)
Other Experimental Indicated Drugs (6)
Organization Involved with Phase 4 Indications (93)
Azienda Ospedaliera Antonio Cardarelli
Badalona Hospital Germans Trias i Pujol
Beijing Weida Cancer Hospital of Chinese Traditional Medical Sciences
Biotech Pharmaceutical Co., Ltd.
Chinese Academy of Medical Sciences
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Fujian Mengchao Hepatobiliary Hospital
Icahn School of Medicine at Mount Sinai
King Faisal Specialist Hospital
Nanjing NingQi Medicine Science and Technology Co., Ltd.
National Cancer Institute, France
National Cancer Institute (NCI)
National Cheng Kung University
People's Liberation Army of China
Second Military Medical University
Shanghai Xuhui District Central Hospital
Simcere Pharmaceutical Co., Ltd
Spanish Clinical Research Network
State University of New York, Buffalo
Organization Involved with Phase 3 Indications (408)
Academic and Community Cancer Research United
All India Institute of Medical Sciences
Amercian Australian Asian Adrenal Alliance (A5)
Anhui College of Traditional Chinese Medicine
Arbeitsgemeinschaft medikamentoese Tumortherapie
Associació per a la Recerca Oncologica, Spain
Association of Urogenital Oncology (AUO)
Associazione Italiana per la Ricerca sul Cancro
Associazione Volontari Pazienti Oncologici
Australasian Gastro-Intestinal Trials Group
Azienda Ospedaliera D Cotugno Hospital of Infectious Diseases
Azienda Ospedaliera San Camillo Forlanini
Azienda Sanitaria Rummo, Benevento, Division of Medical Oncology
Bangabandhu Sheikh Mujib Medical University
Beijing Shenogen Biomedical Co., Ltd
Biocompatibles International plc
Blokhin's Russian Cancer Research Center
Blueprint Medicines Corporation
Boryung Pharmaceutical Company
Bureau of Science and Technology of Guangxi Province, China
Cancer and Leukemia Group B (CALGB)
Cancer Hospital of Guizhou Province
China Academy of Chinese Medical Sciences
Chinese Society of Lung Cancer
Chinese Southwest Oncology Group
City of Hope National Medical Center
Clinical Research Organization, Dhaka, Bangladesh
Clinica Universidad de Navarra
Collaborative Group for Adrenocortical Carcinoma Treatment
Conselho Nacional de Desenvolvimento Científico e Tecnológico
DAHANCA Danish Head and Neck Group
Danish Center for Interventional Research in Radiation Oncology
Danish Head and Neck Cancer Group
Dutch Society of Physicians for Pulmonology and Tuberculosis
Eastern Cooperative Oncology Group
ECOG-ACRIN Cancer Research Group
European Lung Cancer Working Party
European Network for the Study of Adrenal Tumors (ENS@T)
European Organisation for Research and Treatment of Cancer
Evangelischen Diakoniekrankenhaus
Facing Our Risk of Cancer Empowered
Federal University of Rio Grande do Sul
First People's Hospital of Foshan
First People's Hospital of Yulin
Foresee Pharmaceuticals Co., Ltd.
Foshan First People's Hospital
French Immunotherapy Intergroup
French National Agency for Research on AIDS and Viral Hepatitis
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
General Hospital of Chinese Armed Police Forces
German Breast Group Forschungs GmbH
German Federal Ministry of Education and Research
GORTEC (Head and Neck Oncology and Radiotherapy Group)
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Groupe D'Etude des Tumeurs Uro-Genitales
Groupe Oncologie Radiotherapie Tete et Cou
Grupo de Investigación Clínica en Oncología Radioterapia
Grupo Español de Investigación en Cáncer de Ovario
Gruppo Oncologico Italiano di Ricerca Clinica
Guangdong Pharmaceutical University
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou Twelfth People 's Hospital
Hong Kong Nasopharyngeal Cancer Study Group Limited
Hospital Regional Universitario Carlos Haya
Huai'an First People's Hospital
Huai'an Second People's Hospital
Huazhong University of Science and Technology
Indian Council of Medical Research
Innovent Biologics (Suzhou) Co. Ltd.
Institut de Cancérologie de Lorraine
Institut National de la Santé Et de la Recherche Médicale, France
International Atomic Energy Agency
Jiangsu Cancer Institute & Hospital
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Jiangxi Provincial Cancer Hospital
Jilin Provincial Tumor Hospital
Klinikum Vest - Knappschaftskrankenhaus, Recklinghausen
KWF Kanker Bestrijding The Netherlands
Medical Enterprises Europe B.V.
Medigen Biotechnology Corporation
Meizhou City Hospital Of Guangdong Provience
Nanning Second People's Hospital
Ningbo Medical Center Lihuili Eastern Hospital
North Central Cancer Treatment Group
OncoQuest Pharmaceuticals Inc.
Pariser Dermatology Specialists
People's Hospital of Zhongshan
Radiation Therapy Oncology Group
Radiotherapeutisch Instituut Friesland
Royal Marsden Hospital NHS Trust
Shandong Provincial Cancer Hospital
Shanghai Junshi Bioscience Co.,Ltd.
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Singapore Clinical Research Institute
Sino-Swed Pharmaceutical Corporation
St. Antonius Hospital, Nieuwegein
Taiwan Cooperative Oncology Group
Technical University of Munich
The Central Hospital of Lishui City
The Christie NHS Foundation Trust
The Hong Kong Anti-Cancer Society
The Red Cross hospital of Wuzhou
The Red Cross hospital of YuLin
The Second People's Hospital of GuangDong Province
Trans Tasman Radiation Oncology Group
Universidad Autonoma de Barcelona
University Hospital Birmingham NHS Foundation Trust
University of Alabama, Birmingham
University of California, San Francisco
University of Campania Luigi Vanvitelli
University of Erlangen-Nuremberg
University of Naples Frederico II
University of Nice Sophia Antipolis
Organization Involved with Phase 2 Indications (702)
A2 Healthcare Taiwan Corporation
Advanced Accelerator Applications
Aeon Therapeutics (Shanghai) Co., Ltd.
Agency for Science, Technology and Research
Apogee Biotechnology Corporation
Assistance Publique - Hôpitaux de Paris
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)
Auckland District Health Board
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Austrian Breast and Colorectal Cancer Group
Azienda Ospedaliera San Gerardo di Monza
Beijing Konruns Pharmaceutical Co., Ltd.
Betta Pharmaceuticals Co.,Ltd.
Bhagwan Mahaveer Jain Hospital
Big Ten Cancer Research Consortium
Bio-Cancer Treatment International Limited
Breast Cancer Research Foundation
British Columbia Cancer Agency
Bumrungrad International Hospital
Canadian Institutes of Health Research (CIHR)
Cancer Immunotherapy Trials Network
Cancer Research and Biostatistics Clinical Trials Consortium
Cancer Treatment Centers of America
Cantonal Hospital of St. Gallen
CAR-T (Shanghai) Biotechnology Co.,Ltd.
Case Western Reserve University
Center for Clinical and Cosmetic Research
Central European Society for Anticancer Drug Research (CESAR)
Central India Cancer Research Institute, Nagpur
Centre Hospitalier of Chartres
Centre Hospitalier Universitaire de Nīmes
Centro di Riferimento Oncologico - Aviano
Chao Family Comprehensive Cancer Center
China Three Gorges University, Yichang, China
Chinese Anti-Cancer Association
Chinese University of Hong Kong
Choithram Hospital and Research Centre
Christian Medical College, Vellore, India
Chuan An Biotechnology Co., Ltd.
Commissariat A L'energie Atomique
CSM Medical University, Lucknow
Curie Manavata Cancer Center, Nashik, India
Deenanath Mangeshkar Hospital & Research Centre
Department of Radiation Oncology
Dynavax Technologies Corporation
Eastchester Center for Cancer Care
Egyptian Foundation for Cancer Research
European Thoracic Oncology Platform
Fibrolamellar Cancer Foundation
First People's Hospital of Hangzhou
Fundacion Instituto Valenciano de Oncologia
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
GKNM Hospital, Coimbatore, India
Gottfried Wilhelm Leibniz Universität Hannover
Government Medical College, Aurangabad, India
GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU
Grupo Espanol de Tumores Neuroendocrinos (GETNE)
Grupo Espanol Multidisciplinario del Cancer Digestivo
Gruppo Oncologico del Nord-Ovest
Guangzhou Panyu Central Hospital
Guilin Hospital of Traditional Chinese Medicine
Gynecologic Oncology Associates
Gynecologic Oncology of Indiana
GZA Ziekenhuizen Campus Sint-Augustinus
Hangzhou Hospital of Traditional Chinese Medicine
HealthCare Global Enterprise Ltd.
Hellenic Cooperative Oncology Group
Herbert Irving Comprehensive Cancer Center
Hi-Q Marine Biotech International, Ltd.
Hoosier Cancer Research Network
Hôpital Européen Georges-Pompidou
Hospital General Universitario Morales Meseguer
Hospital Universitario Carlos Haya
Hospital Universitario Central de Asturias
Hospital Universitario de Fuenlabrada
Humanity & Health Research Centre
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest
Infinity Pharmaceuticals, Inc.
Institut de Cancerologie de l'Ouest Paul Papin
Institute of Post Graduate Medical Education & Research
Instituto do Cancer do Estado de São Paulo
Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.
Istituto Clinico Humanitas - Rozzano (MI), Italy
Istituto Nazionale per lo Studio e la Cura dei Tumori
Istituto Oncologico Veneto IRCCS
Italian Trial in Medical Oncology
James and Esther King Biomedical Research Program
James Graham Brown Cancer Center
Japan Clinical Cancer Research Organization
Jaslok Hospital and Research Centre, Mumbai, India
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Kansai Hepatobiliary Oncology Group (KHBO)
Katholieke Universiteit Leuven
Korean South West Oncology Group
Korean Urological Oncology Society
Laboratorio Elea S.A.C.I.F. y A.
Latin American Cooperative Oncology Group
Lithuanian University of Health Sciences
Ludwig Institute for Cancer Research
Medizinische Hochschule Hannover
Meenakshi Ammal Dental College and Hospital
Melanoma and Skin Cancer Trials Limited
Memorial Hermann Health System
Memorial Sloan-Kettering Cancer Center
Methodist Cancer Center, Houston, Texas
Moorgreen Hospital, Southampton
Muljibhai Patel Urological Hospital
Nang Kuang Pharmaceutical Co., Ltd.
National Center for Research Resources (NCRR)
National Comprehensive Cancer Network
Nationales Centrum fur Tumorerkrankungen
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Health Research, United Kingdom
National Institute of Dental and Craniofacial Research (NIDCR)
National Institutes of Health (NIH)
National University of Singapore
New Mexico Cancer Care Alliance
Nordic Society for Gynaecologic Oncology
North Eastern Germany Society of Gynaecologic Oncology
Northeast Ohio Medical University
North Sichuan Medical University
Ontario Institute for Cancer Research
Oregon Health and Science University
Ospedale Fatebenefratelli di Roma
Our Lady of Mercy Cancer Center
Our Lady of Mercy Medical Center
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Pharmaceutical Research Associates, Inc. (PRA)
Philipps University of Marburg
Postgraduate Institute of Medical Education and Research
Prostate Cancer Clinical Trials Consortium
Radiological Society of North America
Regional Cancer Centre, Trivandram
Russian Academy of Medical Sciences
Saint Francis Memorial Hospital
Samyang Biopharmaceuticals Corporation
Sarcoma Oncology Research Center, LLC
Scottish Clinical Trials Research Unit
Seth Gordhandas Sunderdas Medical College
Shahid Beheshti University of Medical Sciences
Shandong New Time Pharmaceutical Co., LTD
Shenzhen Hornetcorn Bio-technology Company, LTD
Shenzhen SiBiono GeneTech Co.,Ltd
Shenzhen Third People's Hospital
Shijiazhuang Pharma Group (CSPC)
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Siller Medical T/A Central Brisbane Dermatology
Sinobioway Cell Therapy Co., Ltd.
Southern China Urology Cancer Consortium
South Plains Oncology Consortium
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Spanish Oncology Genito-Urinary Group
Sunshine Lake Pharma Co., Ltd.
Suzhou Kintor Pharmaceutical Inc,
Swiss Group for Clinical Cancer Research
Taizhou Hospital of Zhejiang Province
TCM Biotech International Corp.
Technical University of Dresden
The European Uro-Oncology Group
The Fibrolamellar Cancer Foundation
The First Affiliated Hospital of Clinical Medicine of G.D.P.U.
The First People's Hospital of Changzhou
The First People's Hospital of Hangzhou
The Jewish General Hospital, Montreal QC, Canada
The Kidney Foundation of Canada
The Royal Bournemouth Hospital
The University of Texas, Dallas
Translational Breast Cancer Research Consortium
Translational Research in Oncology
Universidad Autonoma de Madrid
Universidad Complutense de Madrid
University of British Columbia
University of California, Davis
University of California, Irvine
University of California, Los Angeles
University of Colorado, Denver
University of Medicine and Dentistry of New Jersey
University of North Carolina at Chapel Hill
University of Southern California
University of Southern Denmark
University of Texas, Galveston
University of Texas, San Antonio
Urological Institute of Northeastern New York
Vall d'Hebron Institute of Research, Galatea Clinic
Virginia Commonwealth University
Vita-Salute University of Milano. Italy
Vlaams Instituut voor Biotechnologie (VIB)
V M Medical College & Safdarjang Hospital
Ward Veterans General Hospital, Taipei
Organization Involved with Phase 1 Indications (180)
Academic Medical Organization of Southwestern Ontario
Baromedical Research Foundation
Beijing GD Initiative Cell Therapy Technology Co.，Ltd.
BioNumerik Pharmaceuticals, Inc.
Canadian Urological Association Scholarship Fund
Canadian Urological Oncology Group
Cancer Specialists of South Texas, P.A.
CCF Taussig Cancer Solid Tumor Oncology
Cellular Biomedicine Group Ltd.
Department of Health and Human Services
Desai Urological and Maternity Hospital
Eastern Virginia Medical School
Guangdong Xiangxue Precision Medical Technology Co., Ltd
Guangdong Zhaotai InVivo Biomedicine Co. Ltd.
Guangzhou Xiangxue Pharmaceutical Co., Ltd
High Impact Clinical Research Support Program
Hunan Yongren Medical Innovation Co. Ltd.
Lakeland Regional Medical Center
Lotte & John Hecht Memorial Foundation
Nanjing Sike Pharmaceutical Co., Ltd.
NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Kidney and Transplant Institute, Philippines
Nordic Urothelial Cancer Oncology Group
Provectus Biopharmaceuticals, Inc.
Sharp Clinical Oncology Research
Shenzhen Institute for Innovation and Translational Medicine
Shin Nippon Biomedical Laboratories
Sichuan Clover Biopharmaceuticals, Inc.
Sichuan Huiyang Life Science and Technology Corporation
SignalRX Pharmaceuticals, Inc.
St. Luke's Medical Center, Philippines
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Taizhou Mabtech Pharmaceutical Co., Ltd.
Translational Drug Development
Vardhman Mahavir Medical College
Organization Involved with Other Experimental Indications (39)
Howard Hughes Medical Institute
Institute of hepatobiliary surgery,Southwest Hospital
Institute of Liver and Biliary Sciences, India
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
